NCT06861816 Ventilatory Functions and Physical Intolerance in ESRD Adolescents: Response to Program of Walking With Dogs
| NCT ID | NCT06861816 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | End Stage Renal Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-02-05 |
| Primary Completion | 2025-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-02-05 with a primary completion date of 2025-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
adolescents with chronic renal failure going on hemodialysis usually complain many problems including compromised ventilation, early fatigue, early physical intolerance, and bad life quality. incentive spirometer is highly recommended to improve these problems. also, walking program, especially walking with dog, can increase the benefits of incentive spirometer
Eligibility Criteria
Inclusion Criteria: * adolescents (forty) with ESRD * patents on regular hemodiaysis Exclusion Criteria: * cardiac insult * respiratory insult * orthopedic problem * liver insult
Contact & Investigator
Ali MA Ismail, lecturer
PRINCIPAL INVESTIGATOR
Cairo University
Frequently Asked Questions
Who can join the NCT06861816 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 17 Years, studying End Stage Renal Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06861816 currently recruiting?
Yes, NCT06861816 is actively recruiting participants. Contact the research team at ali.mohamed@pt.cu.edu.eg for enrollment information.
Where is the NCT06861816 trial being conducted?
This trial is being conducted at Dokki, Egypt.
Who is sponsoring the NCT06861816 clinical trial?
NCT06861816 is sponsored by Cairo University. The principal investigator is Ali MA Ismail, lecturer at Cairo University. The trial plans to enroll 40 participants.